Drug intelligence / Profile preview

PAA-ACP + AuMQ

Development stage
Preclinical
Modality
Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

PAA-ACP + AuMQ is a combination nanomedicine formulation designed for drug delivery, likely in the context of cancer therapy, typically for carrying a payload such as a chemotherapeutic agent like doxorubicin in similar systems[3]. The components are: - **PAA-ACP** refers to poly(acrylic acid)-coated amorphous calcium phosphate nanoparticles. Poly(acrylic acid) (PAA) is a synthetic anionic polymer known for its water absorption and polyelectrolyte properties[1]. Amorphous calcium phosphate (ACP) serves as a biocompatible mineral phase often used in biomedical applications. - **AuMQ** likely refers to gold-based quantum dots or gold nanomaterials functionalized with quaternary ammonium groups or other moieties ("Q"), which are commonly used as imaging agents or for photothermal/photodynamic therapy. This combination is engineered to serve as a multifunctional drug delivery platform, potentially offering pH-responsive release (due to the ACP core and PAA coating), enhanced cellular uptake, and possibly additional imaging or therapeutic functions from the gold component. Such systems are under investigation primarily for targeted cancer chemotherapy and theranostics[3].

Beyond the preview

Go deeper on PAA-ACP + AuMQ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PAA-ACP + AuMQ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call